CHEMO DISPENSING PIN, MODEL 12495

K024239 · Abbott Laboratories · LHI · Jan 13, 2003 · General Hospital

Device Facts

• Record ID: K024239
• Device Name: CHEMO DISPENSING PIN, MODEL 12495
• Applicant: Abbott Laboratories
• Product Code: LHI · General Hospital
• Decision Date: Jan 13, 2003
• Decision: SESE
• Submission Type: Special
• Regulation: 21 CFR 880.5440
• Device Class: Class 2

Intended Use

For preparing and dispensing I.V. fluids and chemotherapeutic medications from stoppered vials

Device Story

Chemo Dispensing Pin is a sterile, single-use device designed for the transfer of I.V. fluids and chemotherapeutic agents from stoppered vials. It facilitates the safe withdrawal and dispensing of medications. Used by healthcare professionals in clinical environments to minimize exposure during drug preparation. The device functions as a fluid transfer interface between the vial and the administration set or syringe.

Clinical Evidence

No clinical data provided; bench testing only.

Technological Characteristics

Intravascular administration set accessory; sterile, single-use design; intended for fluid transfer from stoppered vials.

Indications for Use

Indicated for the preparation and dispensing of I.V. fluids and chemotherapeutic medications from stoppered vials in a clinical setting.

Regulatory Classification

Identification

An intravascular administration set is a device used to administer fluids from a container to a patient's vascular system through a needle or catheter inserted into a vein. The device may include the needle or catheter, tubing, a flow regulator, a drip chamber, an infusion line filter, an I.V. set stopcock, fluid delivery tubing, connectors between parts of the set, a side tube with a cap to serve as an injection site, and a hollow spike to penetrate and connect the tubing to an I.V. bag or other infusion fluid container.

Special Controls

*Classification.* Class II (special controls). The special control for pharmacy compounding systems within this classification is the FDA guidance document entitled “Class II Special Controls Guidance Document: Pharmacy Compounding Systems; Final Guidance for Industry and FDA Reviewers.” Pharmacy compounding systems classified within the intravascular administration set are exempt from the premarket notification procedures in subpart E of this part and subject to the limitations in § 880.9.

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo consists of a circular border with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is an abstract symbol featuring three stylized human profiles facing to the right, with flowing lines beneath them that could represent water or movement.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

JAN 1 3 2003

Mr. Nicohl R. Wilding Specialist, Regulatory Affairs Abbott Laboratories Hospital Products Division Dept. 0389, Building J-45 200 Abbott Park Road Abbott Park, Illinois 60064-6133

Re: K024239

Trade/Device Name: Chemo Dispensing Pin Regulation Number: 880.5440 Regulation Name: Intravascular Administration Set Regulatory Class: II Product Code: LHI Dated: December 20, 2002 Received: December 23, 2002

Dear Mr. Wilding:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{1}------------------------------------------------

## Page 2 - Mr. Wilding

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at [phone]. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number [phone] or [phone] or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely yours,

Timot A. Ulatowski Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

{2}------------------------------------------------

## Indications for Use Statement

510(k) Number (If known)

Device Name: Chemo Dispensing Pin

Indications For Use:

Chemo Dispensing Pin intended use

の 日本の日本の日本の日本の日本の日本の日本の中古車の中古車の中古車の中古車の中古車の中古車両

For preparing and dispensing I.V. fluids and chemotherapeutic medications from stoppered vials

## PLEASE DO NOT WRITE BELOW THIS LINE -- CONTINUE ON ANOTHER PAGE IF NEEDED

## Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use (per 21 CFR 801.109) OR Over-The_Counter Use________

Patrice Cucenti

(Division of Anesthesiology, General Hospital, Infection Control, Der

510(k) Number. K024239